Lobe Sciences Ltd. (LOBE.CN)

0.0200 +0.0050 (+33.33%) At close: 03:59PM EDT

Lobe Sciences Ltd.

1199 West Hasting Street
Suite 1400
Vancouver, BC V6E 3T5
Canada
949-505-5623
https://www.lobesciences.com

Sector(s): Healthcare
Industry: Biotechnology
Full Time Employees: 

Key Executives

Name	Title	Pay	Exercised	Year Born
Mr. Philip J. Young	CEO, Corporate Secretary & Chairman	312.02k	N/A	1957
Mr. Mathew Lee C.A., CPA	Chief Financial Officer	N/A	N/A	1985
Mr. Baxter F. Phillips III, M.B.A.	COO & Director	N/A	N/A	1975
Mr. Maghsoud Dariani	Chief Science Officer	N/A	N/A	1955

Amounts are as of December 31, 2022 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in CAD.

Description

Lobe Sciences Ltd., a biopharmaceutical company, focuses on the research and development using sub-hallucinatory doses of proprietary psychedelic compounds to improve brain and mental health, and wellness. The company was formerly known as Greenstar Biosciences Corp. and changed its name to Lobe Sciences Ltd. in November 2020. Lobe Sciences Ltd. is headquartered in Vancouver, Canada.

Corporate Governance

Lobe Sciences Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.

Corporate governance scores courtesy of Institutional Shareholder Services (ISS). Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.